Investigation of the permeability characteristics of peri-ulcer and whole ischaemic skin tissue

International Journal of Pharmaceutics

Volumn 357, Issue 1-2, 2008, Pages 1-5

  Walker, Mike ^a   Hadgraft, Jonathan ^b   Lane, Majella E ^b  

^a Department of ConvaTec Inc   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Peri ulcer; Permeability; Skin; Topical delivery; Transdermal delivery; Wound

Indexed keywords

WATER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DRUG DELIVERY SYSTEM; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; ISCHEMIA; MALE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SKIN FUNCTION; SKIN INJURY; SKIN PERMEABILITY; SKIN ULCER;

AGED; DATA INTERPRETATION, STATISTICAL; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; SKIN; SKIN ABSORPTION; SKIN ULCER;

EID: 42749088540     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.01.063     Document Type: Article

References (17)

1. Chen W.Y., Rogers A.A., and Lydon M.J. Characterization of biologic properties of wound fluid collected during early stages of wound healing. J. Invest. Dermatol. 99 (1992) 559-564
2. Chen, W.Y.J., Rogers, A.A., Walker, M., Waring, M., Bowler, P.G., Bishop, S.M., 2004. A rethink of the complexity of chronic wounds-implications for treatment. European Tissue Repair Society, Bulletin 10.2-10.3, pp. 65-69.
3. Cutting K.F. Wound exudate: composition and functions. Br. J. Community Nurs. 8 (2003) 4-9
4. Dugard P.H., Walker M., Mawdlsey S.J., and Scott R.C. Absorption of some glycol ethers through human skin in vitro. Environ. Health. Persp. 57 (1984) 193-197
5. Grinnell F., and Zhu M. Fibronectin degradation in chronic wounds depends on the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin. J. Invest. Dermatol. 106 (1996) 335-341
6. Mustoe T.A., O'Shaughessy, and Kloeters O. Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast. Reconstr. Surg. 117 (2006) 35S-41S
7. Ono I., Gunji H., Suda K., Iwatsuki K., and Kaneko F. Evaluation of cytokines in donor site wound fluids. Scand. J. Plast. Reconstr. Surg. Hand Surg. 28 (1994) 269-273
8. Rao C.N., Ladin D.A., Liu Y.Y., Chilukuri K., Hou Z.Z., and Woodley D.T. Alpha 1-antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds: the inhibitor protects fibronectin from degradation by chronic wound fluid enzymes. J. Invest. Dermatol. 105 (1995) 572-578
9. Simon D.A., Dix F.P., and McCollum C.N. Management of venous leg ulcers. BMJ 328 (2004) 1358-1362
10. Walker M., Dugard P.H., and Scott R.C. In vitro percutaneous absorption studies: a comparison of human and laboratory species. Human. Toxicol. 2 (1983) 561-562
11. Walker, M., Patrick, K., Lian, P., Scriven, M., 1996. The European Tissue Repair Society Focused Meeting on the Chronic Wound, Cardiff, UK.
12. Walker M., Hulme T.A., Rippon M.G., Walmsle R.S., Gunnigle S., Lewin M., and Winsey S. In vitro model(s) for the percutaneous delivery of active tissue repair agents. J. Pharm. Sci. 86 (1997) 1379-1384
13. White R.J., and Cutting K.F. Interventions to avoid maceration of the skin and wound bed. Br. J. Nurs. 12 (2003) 1186-1201
14. Wysocki A.B., Staiano-Coico L., and Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J. Invest. Dermatol. 101 (1993) 64-68
15. Wysocki A.B. Wound fluids and the pathogenesis of chronic wounds. J. Wound Ostomy Continence Nurs. 23 (1996) 283-290
16. Yager D.R., and Nwomeh B.C. The proteolytic environment of chronic wounds. Wound Repair Regen. 7 (1999) 433-441
17. Yager D.R., Zhang L.Y., Liang H.X., Diegelmann R.F., and Cohen I.K. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J. Invest. Dermatol. 107 (1996) 743-748